The Sept edition of MedNous is now out featuring commentary on the financial markets by Juliette Audet at Forbion; an analysis on how pharma manages organisational complexity by Aleksandra Grasso at Novasecta and a review of FDA guidance on psychedelics by Daniel Karlin and Robert Barrow at Mind Medicine. Our editorial board member Jean-Claude Muller also analyses R&D policy at large pharma. This is in addition to our tables and corporate reporting. For a complimentary copy please write to editor@evernow.eu